Phreesia, Inc. (NYSE:PHR) CFO Sells $159,135.37 in Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 5,827 shares of the company's stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $159,135.37. Following the completion of the sale, the chief financial officer now directly owns 141,846 shares in the company, valued at approximately $3,873,814.26. The trade was a 3.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Wednesday, January 15th, Balaji Gandhi sold 836 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $22,555.28.
• On Monday, January 6th, Balaji Gandhi sold 3,195 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $85,018.95.

Phreesia Stock Performance

PHR traded down $0.06 during mid-day trading on Wednesday, reaching $27.29. 389,445 shares of the company traded hands, compared to its average volume of 386,096. The stock has a market capitalization of $1.59 billion, a P/E ratio of -18.56 and a beta of 0.94. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.16. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company's fifty day moving average price is $23.77 and its 200-day moving average price is $22.94.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. Phreesia's revenue was up 16.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.58) earnings per share. On average, sell-side analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Hedge Funds Weigh In On Phreesia

A number of institutional investors and hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC grew its holdings in Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company's stock valued at $33,000 after purchasing an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp purchased a new position in shares of Phreesia during the 2nd quarter valued at about $202,000. Point72 DIFC Ltd bought a new position in shares of Phreesia during the 2nd quarter valued at approximately $209,000. XTX Topco Ltd purchased a new stake in Phreesia in the 3rd quarter worth approximately $247,000. Finally, Hsbc Holdings PLC bought a new stake in Phreesia during the 2nd quarter worth approximately $301,000. Hedge funds and other institutional investors own 92.10% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on PHR. Needham & Company LLC restated a "buy" rating and issued a $29.00 price target on shares of Phreesia in a research note on Friday, January 10th. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and increased their target price for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. JMP Securities reaffirmed a "market outperform" rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Robert W. Baird cut their price objective on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research report on Wednesday, December 11th. Finally, Citigroup lifted their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a "buy" rating in a report on Friday, January 10th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.